CLM296: a highly selective inhibitor targeting ALDH1A3-driven tumor growth and metastasis in breast...
Aldehyde dehydrogenase 1A3 (ALDH1A3) increases tumor growth, metastasis, and chemoresistance in many solid tumors, including triple-negative breast cancer (TNBC), glioblastoma, melanoma, lung, and...
biorxiv.org